National Bank of Canada
MIRM icon

National Bank of Canada’s Mirum Pharmaceuticals MIRM Stock Holding History

National Bank of Canada’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17
Closed -$1.34K – 3112
2025
Q4 		$1.34K Buy
+17
New +$1.22K ﹤0.01% 2603
2025
Q1 		– Sell
-20
Closed -$827 – 3038
2024
Q4 		$827 Sell
20
-323
-94% -$13.5K ﹤0.01% 2664
2024
Q3 		$13.4K Buy
343
+323
+1,615% +$12.9K ﹤0.01% 2017
2024
Q2 		$680 Buy
+20
New +$524 ﹤0.01% 2536

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

National Bank of Canada's MIRM Position: Q1 2026 in Review

National Bank of Canada sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 17 shares — an estimated $1.34K sold.

National Bank of Canada first reported a position in MIRM in Q2 2024 and held it in 4 quarters. The position peaked at $13.4K in Q3 2024. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • National Bank of Canada reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • National Bank of Canada sold 17 Mirum Pharmaceuticals shares in Q1 2026, an estimated $1.34K.
  • National Bank of Canada first reported a position in Mirum Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • National Bank of Canada's Mirum Pharmaceuticals position peaked at $13.4K in Q3 2024.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.